chr15-51341893-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181789.4(GLDN):c.209C>A(p.Ala70Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000279 in 1,432,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_181789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLDN | NM_181789.4 | c.209C>A | p.Ala70Asp | missense_variant | 1/10 | ENST00000335449.11 | |
GLDN | XM_017022121.2 | c.209C>A | p.Ala70Asp | missense_variant | 1/9 | ||
GLDN | XM_017022125.1 | c.209C>A | p.Ala70Asp | missense_variant | 1/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLDN | ENST00000335449.11 | c.209C>A | p.Ala70Asp | missense_variant | 1/10 | 2 | NM_181789.4 | P1 | |
GLDN | ENST00000558286.5 | n.20C>A | non_coding_transcript_exon_variant | 1/3 | 1 | ||||
GLDN | ENST00000560215.5 | c.98C>A | p.Ala33Asp | missense_variant | 1/4 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000100 AC: 2AN: 199706Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 111644
GnomAD4 exome AF: 0.00000279 AC: 4AN: 1432972Hom.: 0 Cov.: 30 AF XY: 0.00000281 AC XY: 2AN XY: 712346
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.209C>A (p.A70D) alteration is located in exon 1 (coding exon 1) of the GLDN gene. This alteration results from a C to A substitution at nucleotide position 209, causing the alanine (A) at amino acid position 70 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at